GETTING PRODUCTS TO PATIENTS

ABOUT US:

  • New Rhein is a private equity investment firm focused on healthcare therapeutics and medical devices
  • Our partners, associates, and advisors are former industry executives with operational and transactional experience
  • We invest in businesses that utilize proven products in new applications; specifically clinically de-risked assets and existing molecules with newly discovered uses and purposes
  • We believe that “innovation drives greater risk-adjusted value than invention” and that major unmet medical needs can be addressed by existing solutions, improving health economic outcomes in doing so
New Rhein serves as a business “incubator”

 

We bring active operational support to our companies to reduce risk, improve returns, and maximize the probability of bringing new treatments to patients.

We support our companies on all aspects of life sciences and medical product development, including (but not limited to):

  • Clinical trial design
  • Regulatory approval
  • Sales & marketing
  • Pricing & reimbursement
  • Strategy & operations
  • Industry partnerships

WHY WE ARE CALLED NEW RHEIN

The Rhein river connected the 19th century chemical industry and is the principle birthplace of the pharma industry.

Still today, many of the largest pharma companies call the Rhein riverbanks their home.

VIEW OUR INVESTMENT CRITERIA

WANT TO WORK TOGETHER? VIEW OUR INVESTMENT CRITERIA & SEND US A PITCH!